AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
2min chapter
How a big biotech’s start-up gamble went wrong
Behind the Money
The Importance of FDA Approval for Grail Tests
Illumina's 80% market share meant that the company had been able to make their investors a lot of consistent money for many years. While grail was working on getting that full FDA approval, the startup actually began selling its test in 2021 - making it available to people in the US with a doctor's prescription. Jamie says not everyone feels like Valerie. We've got a lot of critics out there who say they're trying to sell these things to the public before they're fully proven that they actually work. They haven't done enough testing and they haven't done the right trials yet to really prove that these products should be out in the market.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode